Abstract

We investigated fluorescence detection limit of our chemophototherapy drug with custom design spatial frequency domain endoscope in phantoms and in mice. Our results indicate that the scope can quantify ~1ug/mL Doxorubicin and 0.25ug/mL porphyrin with sufficient SNR.

© 2020 The Author(s)

PDF Article
More Like This
A dual-modal, dual-channel, mesoscopic-scale theranostic endoscope for quantitative imaging, monitoring, and light-triggering of chemodrug release from liposomes in vivo

Ulas Sunar, Jeremy Kress, Daniel J. Rohrbach, Kevin A. Carter, Dandan Luo, Chien Poon, Semra Aygun-Sunar, Shuai Shao, Shashikant Lele, and Jonathan F. Lovell
CF4B.4 Clinical and Translational Biophotonics (Translational) 2018

Light-triggered doxorubicin release quantified by spatial frequency domain imaging and diffuse optical spectroscopy

Ulas Sunar, Jeremy Kress, Daniel J. Rohrbach, Kevin A. Carter, Dandan Luo, Shuai Shao, Shashikant Lele, and Jonathan F. Lovell
JW4A.3 Cancer Imaging and Therapy (Cancer) 2016

AdaBoost-based multi-wavelength spatial frequency domain imaging for human colorectal tissue assessment

Shuying Li, Yifeng Zeng, William C. Chapman, Mohsen Erfanzadeh, Zahra Alipour, Heba Abdelal, Matthew Mutch, and Quing Zhu
SM2D.7 Optical Tomography and Spectroscopy (OTS) 2020

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access OSA Member Subscription